Atlas Trials

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

Clinical trial NCT07598643 · RECRUITING

Trial details

NCT number
NCT07598643
Sponsor
University of Colorado, Denver
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Down Syndrome
Start date
2026-05-01
Primary completion
2030-08-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.